The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global GLP Analogs Market Research Report 2025
Synopsis
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global GLP Analogs market was valued at US$ 5387 million in 2023 and is anticipated to reach US$ 7350.9 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The Glucagon-like peptide 1 (GLP-1) market is driven by the increasing prevalence of diabetes and the growing demand for effective and innovative diabetes treatments. GLP-1 is a hormone that plays a crucial role in regulating blood sugar levels and is used in the treatment of type 2 diabetes. The rise in the number of diabetic patients and the need for better glycemic control contribute to market growth as GLP-1-based therapies offer significant benefits, including glucose-lowering effects and weight management. Moreover, advancements in GLP-1 analog formulations, such as long-acting and once-weekly options, have improved patient compliance and treatment outcomes. However, the market also faces challenges, including the cost of GLP-1 treatments and the need for further research to optimize dosing and combination therapies. Additionally, addressing the barriers to GLP-1 adoption, such as injection-related fears, can pose obstacles for broader market penetration. To succeed, companies must focus on research and development to offer innovative and cost-effective GLP-1 therapies, collaborate with healthcare providers to optimize treatment regimens, and address the challenges to meet the increasing demand for effective and well-tolerated diabetes treatments based on GLP-1.
This report aims to provide a comprehensive presentation of the global market for GLP Analogs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP Analogs.
Report Scope
The GLP Analogs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GLP Analogs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP Analogs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Segment by Type
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP Analogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP Analogs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global GLP Analogs market was valued at US$ 5387 million in 2023 and is anticipated to reach US$ 7350.9 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The Glucagon-like peptide 1 (GLP-1) market is driven by the increasing prevalence of diabetes and the growing demand for effective and innovative diabetes treatments. GLP-1 is a hormone that plays a crucial role in regulating blood sugar levels and is used in the treatment of type 2 diabetes. The rise in the number of diabetic patients and the need for better glycemic control contribute to market growth as GLP-1-based therapies offer significant benefits, including glucose-lowering effects and weight management. Moreover, advancements in GLP-1 analog formulations, such as long-acting and once-weekly options, have improved patient compliance and treatment outcomes. However, the market also faces challenges, including the cost of GLP-1 treatments and the need for further research to optimize dosing and combination therapies. Additionally, addressing the barriers to GLP-1 adoption, such as injection-related fears, can pose obstacles for broader market penetration. To succeed, companies must focus on research and development to offer innovative and cost-effective GLP-1 therapies, collaborate with healthcare providers to optimize treatment regimens, and address the challenges to meet the increasing demand for effective and well-tolerated diabetes treatments based on GLP-1.
This report aims to provide a comprehensive presentation of the global market for GLP Analogs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP Analogs.
Report Scope
The GLP Analogs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GLP Analogs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP Analogs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Segment by Type
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP Analogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP Analogs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 GLP Analogs Market Overview
1.1 Product Overview and Scope of GLP Analogs
1.2 GLP Analogs Segment by Type
1.2.1 Global GLP Analogs Market Value Comparison by Type (2024-2030)
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 GLP Analogs Segment by Application
1.3.1 Global GLP Analogs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global GLP Analogs Market Size Estimates and Forecasts
1.4.1 Global GLP Analogs Revenue 2019-2030
1.4.2 Global GLP Analogs Sales 2019-2030
1.4.3 Global GLP Analogs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GLP Analogs Market Competition by Manufacturers
2.1 Global GLP Analogs Sales Market Share by Manufacturers (2019-2024)
2.2 Global GLP Analogs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GLP Analogs Average Price by Manufacturers (2019-2024)
2.4 Global GLP Analogs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP Analogs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP Analogs, Product Type & Application
2.7 GLP Analogs Market Competitive Situation and Trends
2.7.1 GLP Analogs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest GLP Analogs Players Market Share by Revenue
2.7.3 Global GLP Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GLP Analogs Retrospective Market Scenario by Region
3.1 Global GLP Analogs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GLP Analogs Global GLP Analogs Sales by Region: 2019-2030
3.2.1 Global GLP Analogs Sales by Region: 2019-2024
3.2.2 Global GLP Analogs Sales by Region: 2025-2030
3.3 Global GLP Analogs Global GLP Analogs Revenue by Region: 2019-2030
3.3.1 Global GLP Analogs Revenue by Region: 2019-2024
3.3.2 Global GLP Analogs Revenue by Region: 2025-2030
3.4 North America GLP Analogs Market Facts & Figures by Country
3.4.1 North America GLP Analogs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GLP Analogs Sales by Country (2019-2030)
3.4.3 North America GLP Analogs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP Analogs Market Facts & Figures by Country
3.5.1 Europe GLP Analogs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GLP Analogs Sales by Country (2019-2030)
3.5.3 Europe GLP Analogs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP Analogs Market Facts & Figures by Country
3.6.1 Asia Pacific GLP Analogs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GLP Analogs Sales by Country (2019-2030)
3.6.3 Asia Pacific GLP Analogs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America GLP Analogs Market Facts & Figures by Country
3.7.1 Latin America GLP Analogs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GLP Analogs Sales by Country (2019-2030)
3.7.3 Latin America GLP Analogs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GLP Analogs Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP Analogs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GLP Analogs Sales by Country (2019-2030)
3.8.3 Middle East and Africa GLP Analogs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP Analogs Sales by Type (2019-2030)
4.1.1 Global GLP Analogs Sales by Type (2019-2024)
4.1.2 Global GLP Analogs Sales by Type (2025-2030)
4.1.3 Global GLP Analogs Sales Market Share by Type (2019-2030)
4.2 Global GLP Analogs Revenue by Type (2019-2030)
4.2.1 Global GLP Analogs Revenue by Type (2019-2024)
4.2.2 Global GLP Analogs Revenue by Type (2025-2030)
4.2.3 Global GLP Analogs Revenue Market Share by Type (2019-2030)
4.3 Global GLP Analogs Price by Type (2019-2030)
5 Segment by Application
5.1 Global GLP Analogs Sales by Application (2019-2030)
5.1.1 Global GLP Analogs Sales by Application (2019-2024)
5.1.2 Global GLP Analogs Sales by Application (2025-2030)
5.1.3 Global GLP Analogs Sales Market Share by Application (2019-2030)
5.2 Global GLP Analogs Revenue by Application (2019-2030)
5.2.1 Global GLP Analogs Revenue by Application (2019-2024)
5.2.2 Global GLP Analogs Revenue by Application (2025-2030)
5.2.3 Global GLP Analogs Revenue Market Share by Application (2019-2030)
5.3 Global GLP Analogs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP Analogs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk GLP Analogs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca GLP Analogs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca GLP Analogs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lily
6.3.1 Eli Lily Corporation Information
6.3.2 Eli Lily Description and Business Overview
6.3.3 Eli Lily GLP Analogs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lily GLP Analogs Product Portfolio
6.3.5 Eli Lily Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK GLP Analogs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK GLP Analogs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi GLP Analogs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi GLP Analogs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb GLP Analogs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb GLP Analogs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Amylin
6.6.1 Amylin Corporation Information
6.6.2 Amylin Description and Business Overview
6.6.3 Amylin GLP Analogs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amylin GLP Analogs Product Portfolio
6.7.5 Amylin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP Analogs Industry Chain Analysis
7.2 GLP Analogs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP Analogs Production Mode & Process
7.4 GLP Analogs Sales and Marketing
7.4.1 GLP Analogs Sales Channels
7.4.2 GLP Analogs Distributors
7.5 GLP Analogs Customers
8 GLP Analogs Market Dynamics
8.1 GLP Analogs Industry Trends
8.2 GLP Analogs Market Drivers
8.3 GLP Analogs Market Challenges
8.4 GLP Analogs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global GLP Analogs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global GLP Analogs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global GLP Analogs Market Competitive Situation by Manufacturers in 2023
Table 4. Global GLP Analogs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global GLP Analogs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global GLP Analogs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global GLP Analogs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market GLP Analogs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of GLP Analogs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of GLP Analogs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GLP Analogs, Product Type & Application
Table 12. Global Key Manufacturers of GLP Analogs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP Analogs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP Analogs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP Analogs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global GLP Analogs Sales by Region (2019-2024) & (K Units)
Table 18. Global GLP Analogs Sales Market Share by Region (2019-2024)
Table 19. Global GLP Analogs Sales by Region (2025-2030) & (K Units)
Table 20. Global GLP Analogs Sales Market Share by Region (2025-2030)
Table 21. Global GLP Analogs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global GLP Analogs Revenue Market Share by Region (2019-2024)
Table 23. Global GLP Analogs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global GLP Analogs Revenue Market Share by Region (2025-2030)
Table 25. North America GLP Analogs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America GLP Analogs Sales by Country (2019-2024) & (K Units)
Table 27. North America GLP Analogs Sales by Country (2025-2030) & (K Units)
Table 28. North America GLP Analogs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America GLP Analogs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe GLP Analogs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe GLP Analogs Sales by Country (2019-2024) & (K Units)
Table 32. Europe GLP Analogs Sales by Country (2025-2030) & (K Units)
Table 33. Europe GLP Analogs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe GLP Analogs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific GLP Analogs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific GLP Analogs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific GLP Analogs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific GLP Analogs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific GLP Analogs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America GLP Analogs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America GLP Analogs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America GLP Analogs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America GLP Analogs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America GLP Analogs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa GLP Analogs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa GLP Analogs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa GLP Analogs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa GLP Analogs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa GLP Analogs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global GLP Analogs Sales (K Units) by Type (2019-2024)
Table 51. Global GLP Analogs Sales (K Units) by Type (2025-2030)
Table 52. Global GLP Analogs Sales Market Share by Type (2019-2024)
Table 53. Global GLP Analogs Sales Market Share by Type (2025-2030)
Table 54. Global GLP Analogs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global GLP Analogs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global GLP Analogs Revenue Market Share by Type (2019-2024)
Table 57. Global GLP Analogs Revenue Market Share by Type (2025-2030)
Table 58. Global GLP Analogs Price (USD/Unit) by Type (2019-2024)
Table 59. Global GLP Analogs Price (USD/Unit) by Type (2025-2030)
Table 60. Global GLP Analogs Sales (K Units) by Application (2019-2024)
Table 61. Global GLP Analogs Sales (K Units) by Application (2025-2030)
Table 62. Global GLP Analogs Sales Market Share by Application (2019-2024)
Table 63. Global GLP Analogs Sales Market Share by Application (2025-2030)
Table 64. Global GLP Analogs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global GLP Analogs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global GLP Analogs Revenue Market Share by Application (2019-2024)
Table 67. Global GLP Analogs Revenue Market Share by Application (2025-2030)
Table 68. Global GLP Analogs Price (USD/Unit) by Application (2019-2024)
Table 69. Global GLP Analogs Price (USD/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk GLP Analogs Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca GLP Analogs Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Eli Lily Corporation Information
Table 81. Eli Lily Description and Business Overview
Table 82. Eli Lily GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lily GLP Analogs Product
Table 84. Eli Lily Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. GSK GLP Analogs Product
Table 89. GSK Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi GLP Analogs Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Bristol-Myers Squibb GLP Analogs Product
Table 99. Bristol-Myers Squibb Recent Developments/Updates
Table 100. Amylin Corporation Information
Table 101. Amylin Description and Business Overview
Table 102. Amylin GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Amylin GLP Analogs Product
Table 104. Amylin Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. GLP Analogs Distributors List
Table 108. GLP Analogs Customers List
Table 109. GLP Analogs Market Trends
Table 110. GLP Analogs Market Drivers
Table 111. GLP Analogs Market Challenges
Table 112. GLP Analogs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of GLP Analogs
Figure 2. Global GLP Analogs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global GLP Analogs Market Share by Type in 2023 & 2030
Figure 4. Exenatied Product Picture
Figure 5. Liraglutide Product Picture
Figure 6. Lixisenatide Product Picture
Figure 7. Albiglutide Product Picture
Figure 8. Dulaglutide Product Picture
Figure 9. Global GLP Analogs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global GLP Analogs Market Share by Application in 2023 & 2030
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Other
Figure 14. Global GLP Analogs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global GLP Analogs Market Size (2019-2030) & (US$ Million)
Figure 16. Global GLP Analogs Sales (2019-2030) & (K Units)
Figure 17. Global GLP Analogs Average Price (USD/Unit) & (2019-2030)
Figure 18. GLP Analogs Report Years Considered
Figure 19. GLP Analogs Sales Share by Manufacturers in 2023
Figure 20. Global GLP Analogs Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest GLP Analogs Players: Market Share by Revenue in 2023
Figure 22. GLP Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global GLP Analogs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America GLP Analogs Sales Market Share by Country (2019-2030)
Figure 25. North America GLP Analogs Revenue Market Share by Country (2019-2030)
Figure 26. United States GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe GLP Analogs Sales Market Share by Country (2019-2030)
Figure 29. Europe GLP Analogs Revenue Market Share by Country (2019-2030)
Figure 30. Germany GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific GLP Analogs Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific GLP Analogs Revenue Market Share by Region (2019-2030)
Figure 37. China GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America GLP Analogs Sales Market Share by Country (2019-2030)
Figure 47. Latin America GLP Analogs Revenue Market Share by Country (2019-2030)
Figure 48. Mexico GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa GLP Analogs Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa GLP Analogs Revenue Market Share by Country (2019-2030)
Figure 53. Turkey GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE GLP Analogs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of GLP Analogs by Type (2019-2030)
Figure 57. Global Revenue Market Share of GLP Analogs by Type (2019-2030)
Figure 58. Global GLP Analogs Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of GLP Analogs by Application (2019-2030)
Figure 60. Global Revenue Market Share of GLP Analogs by Application (2019-2030)
Figure 61. Global GLP Analogs Price (USD/Unit) by Application (2019-2030)
Figure 62. GLP Analogs Value Chain
Figure 63. GLP Analogs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
